These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 17035408)

  • 1. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
    Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.
    Cohen YC; Liu KS; Heyden NL; Carides AD; Anderson KM; Daifotis AG; Gann PH
    J Natl Cancer Inst; 2007 Sep; 99(18):1366-74. PubMed ID: 17848668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series.
    Moreira DM; Anderson T; Gerber L; Thomas JA; Bañez LL; McKeever MG; Hoyo C; Grant D; Jayachandran J; Freedland SJ
    Cancer Causes Control; 2011 Jul; 22(7):977-83. PubMed ID: 21562753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
    Kane CJ; Bassett WW; Sadetsky N; Silva S; Wallace K; Pasta DJ; Cooperberg MR; Chan JM; Carroll PR
    J Urol; 2005 Mar; 173(3):732-6. PubMed ID: 15711258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
    Rodriguez C; Freedland SJ; Deka A; Jacobs EJ; McCullough ML; Patel AV; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):63-9. PubMed ID: 17179486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometrics and prostate cancer risk.
    Littman AJ; White E; Kristal AR
    Am J Epidemiol; 2007 Jun; 165(11):1271-9. PubMed ID: 17395597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
    Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
    Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and the risk of prostate cancer in Italy.
    Tavani A; Gallus S; Bertuzzi M; Dal Maso L; Zucchetto A; Negri E; Franceschi S; Ramazzotti V; Montella M; La Vecchia C
    Eur Urol; 2005 Mar; 47(3):313-7; discussion 317. PubMed ID: 15716192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited.
    Klein EA; Tangen CM; Goodman PJ; Lippman SM; Thompson IM
    J Clin Oncol; 2005 Oct; 23(30):7460-6. PubMed ID: 16157937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
    Freedland SJ; Terris MK; Platz EA; Presti JC
    Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
    Thompson IM; Lucia MS; Redman MW; Darke A; La Rosa FG; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM; Pauler Ankerst D; Chi C; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA
    J Clin Oncol; 2007 Jul; 25(21):3076-81. PubMed ID: 17634486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade prostate cancer and finasteride.
    Lebdai S; Bigot P; Azzouzi AR
    BJU Int; 2010 Feb; 105(4):456-9. PubMed ID: 19930174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Height, body weight, and risk of prostate cancer.
    Giovannucci E; Rimm EB; Stampfer MJ; Colditz GA; Willett WC
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):557-63. PubMed ID: 9264267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A better prognosis for obese men with prostate cancer.
    Daniell HW
    J Urol; 1996 Jan; 155(1):220-5. PubMed ID: 7490839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia.
    Fowke JH; Motley SS; Wills M; Cookson MS; Concepcion RS; Eckstein CW; Chang SS; Smith JA
    Cancer Causes Control; 2007 May; 18(4):375-84. PubMed ID: 17334811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging.
    Hubbard JS; Rohrmann S; Landis PK; Metter EJ; Muller DC; Andres R; Carter HB; Platz EA
    Urology; 2004 Feb; 63(2):253-8. PubMed ID: 14972466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and the risk of prostate cancer (United States).
    Bradbury BD; Wilk JB; Kaye JA
    Cancer Causes Control; 2005 Aug; 16(6):637-41. PubMed ID: 16049801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.